Details of the Drug Reposition

General Information of This Drug (ID: DMS0L6J)

• Drug Name: NY-ESO-TCR (DMS0L6J)

Information on Drug Reposition of This Drug

5 Phase 1/2 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Multiple myeloma	DISEWP9B	2A83	Phase 1/2	[1]
Myxoid round cell liposarcoma	DISQ4VWB	2B59	Phase 1/2	[1]
Synovial sarcoma	DISEZJS7	2B5A	Phase 1/2	[1]
Melanoma	DIS1RRCY	2C30	Phase 1/2	[1]
Ovarian cancer	DISZJHAP	2C73	Phase 1/2	[1]

References

• [1] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)